Drug
Cep 37247
Cep 37247: highest development phase Phase 1/2, developed by Teva. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Teva
Trials
| Drug | Phase | Indication |
|---|---|---|
| CEP-37247 NCT01240876 | Phase 1/2 | Sciatica |
Latest
No recent events.
Follow Cep 37247 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.